Aristal

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aristal

Understanding Aristal

Aristal is a pharmacological treatment belonging to the class of medications known as atypical antipsychotics, or second-generation antipsychotics (SGAs). It is primarily utilized in the management of certain psychiatric and neurological conditions. The medication works by influencing the activity of specific chemical messengers in the brain, notably dopamine and serotonin, which play key roles in regulating mood, perception, and behavior.

Mechanism of Action

Unlike older antipsychotic medications that primarily block dopamine receptors, Aristal acts as a partial agonist at dopamine D2 receptors. This means it can either increase or decrease dopamine activity depending on the existing levels in the brain, aiming to achieve a more balanced state. Additionally, it interacts with various serotonin receptors, contributing to its overall effect on stabilizing mental health symptoms.

Primary Uses

Aristal is commonly prescribed for several conditions involving the central nervous system:

  • Schizophrenia: It helps manage symptoms such as hallucinations, delusions, and disorganized thinking.
  • Bipolar I Disorder: It is used to address manic or mixed episodes and can be used as a maintenance treatment to help stabilize mood.
  • Major Depressive Disorder: In some cases, it is used as an add-on treatment for individuals who have not achieved an adequate response to antidepressant therapy alone.
  • Irritability associated with Autistic Disorder: It may be used to help manage behavioral symptoms such as aggression or mood swings in specific pediatric populations.

Characteristics of the Medication

Aristal is designed to provide symptomatic relief by modulating brain chemistry. Because it belongs to the atypical class of antipsychotics, it is generally associated with a different profile of side effects compared to first-generation medications, particularly regarding movement-related issues. However, its impact varies significantly between individuals based on their specific physiological makeup and the condition being treated.

Regulatory References

  1. MedlinePlus - NIH

What side effects are possible with Aristal?

Possible Side Effects and Safety Information

Boxed Warnings and Serious Safety Concerns

The FDA has issued a Boxed Warning regarding the use of Aristal (aripiprazole lauroxil) in elderly patients with dementia-related psychosis, due to an increased risk of death. The drug is not approved for this use. A second Boxed Warning notes an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to 24 years old) when the drug is used as an antidepressant.

Clinically significant adverse reactions include the potentially fatal Neuroleptic Malignant Syndrome (NMS), characterized by high fever and muscle rigidity, and Tardive Dyskinesia (TD), involving involuntary movements, which may become irreversible with increased treatment duration and cumulative dose. The risk of TD necessitates ongoing monitoring.

Key Adverse Reactions and Metabolic Risks

The most commonly observed adverse reaction (incidence ge 5% and at least twice the rate of placebo in schizophrenia trials) is akathisia, an inner sense of restlessness. Other key adverse reactions involve metabolic changes, including the potential for hyperglycemia (high blood sugar, sometimes leading to ketoacidosis), weight gain, and dyslipidemia (abnormal lipid levels), which require regular monitoring of blood glucose and lipid profiles.

Other Important Safety Considerations

Aristal has been associated with pathological gambling and other compulsive behaviors (e.g., compulsive sexual urges, spending, or eating). Physicians should consider dose reduction or discontinuation if these urges develop. Other documented risks include orthostatic hypotension (dizziness upon standing, increasing the risk of falls), seizures, and changes in blood cell counts (leukopenia/neutropenia). Patients exposed to Aristal during the third trimester of pregnancy may have newborns who experience extrapyramidal and/or withdrawal symptoms.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Aristal (aripiprazole lauroxil) is managed based on the known human experience with its active component, oral aripiprazole. An overdose involving this type of medication requires immediate medical attention and professional emergency management due to the risk of serious complications.

Documented Overdose Signs

Overdose of the active substance has been associated with central nervous system and cardiovascular effects. Reported clinical manifestations include:

  • Somnolence (drowsiness)
  • Vomiting
  • Tremor
  • Medically significant signs, such as metabolic acidosis, rhabdomyolysis (muscle breakdown), hypertension (high blood pressure), loss of consciousness, and ECG abnormalities (e.g., QTc prolongation and bradyarrhythmia).

Emergency Management

There is no specific antidote for an overdose with this extended-release formulation. Management should consist of general supportive measures, including close medical supervision and continuous monitoring, especially of the cardiovascular system via ECG monitoring for potential arrhythmias. Establishing a patent airway with adequate ventilation and oxygenation is necessary. Procedures such as gastric lavage and administration of activated charcoal may be indicated. Due to the extended-release nature of aripiprazole lauroxil, the active substance persists in the system, and its management is complicated by its slow systemic clearance. Hemodialysis is unlikely to be useful as a primary treatment.

Therapeutic Uses of Aristal

Aristal (Ketoprofen) is used to provide symptomatic relief across several key domains where symptoms related to physical discomfort, inflammation, and fever create noticeable physiological strain. The therapeutic benefit is aligned with domains involving significant symptom expression and is considered relevant when supportive symptom management is appropriate. The medication is commonly used to help with symptoms in conditions marked by increased discomfort.

The medicine is generally used to help manage the symptom burden in conditions characterized by chronic or acute musculoskeletal discomfort, such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gout. It is also applied when appropriate for easing symptoms like sprains, strains, post-operative discomfort, and primary dysmenorrhea. The medication provides supportive relief when symptoms interfere with routine activities and contributes to easing the overall symptom load during periods of heightened symptoms.

Quick Fact: Relief for Inflammatory Symptoms

Property Description
Primary Actions Pain relief, inflammation reduction, fever control
Symptom Focus Joint pain, swelling, stiffness, and acute aches
Typical Use Chronic arthritis management and acute injury episodes
Patient Benefit Contributes to improved comfort and assists with maintaining functional stability

Regulatory References

  1. NIH MedlinePlus Drug Information on Ketoprofen

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Aristal — Official Regulatory Information

The eligibility profile for Aristal (Ketoprofen) is defined by official regulatory documentation, which specifies populations for whom the medicine is permitted, restricted, or strictly prohibited.


Populations for whom use is Contraindicated (Must Not Use)

Contraindication Status Eligibility Constraint
Absolute Prohibition Patients with known hypersensitivity to Ketoprofen or any component, or those in whom aspirin or other NSAIDs precipitate asthma, urticaria, or rhinitis.
Physiological State Patients in the third trimester of pregnancy (starting at 30 weeks gestation) and patients receiving treatment for pain after CABG surgery.
Active Disease Patients with active peptic ulcers or active inflammatory diseases of the gastrointestinal tract.

Populations with Restricted or Conditional Use

Restriction Status Eligibility Constraint
Not Recommended Nursing mothers (breastfeeding) and patients in the first and second trimesters of pregnancy (use must be strictly limited).
Use with Caution Older adults (geriatric patients) due to increased risk of adverse reactions; patients with impaired renal or hepatic function; and patients with a history of congestive heart failure or GI disease.
Age Restriction The safety and efficacy have not been established for the oral form in the pediatric population (under 18 years of age).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Aristal (Ketoprofen) classifies interactions based on pharmacokinetic and pharmacodynamic outcomes that alter patient exposure or risk.

Contraindicated Combinations and Exposure Alterations

Aristal is officially contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Use is also prohibited in patients who have experienced allergic-type reactions, such as asthma or urticaria, after taking aspirin or other nonsteroidal anti-inflammatory drugs. Co-administration with Probenecid is documented to reduce Ketoprofen’s plasma clearance, resulting in officially acknowledged increased systemic exposure. Furthermore, Ketoprofen can reduce the renal clearance of Lithium and Methotrexate, leading to an official risk of elevated plasma concentrations of these co-administered drugs. Antacids do not interfere with the rate or extent of Ketoprofen absorption.

Pharmacodynamic Risks and Constraints

A synergistic increase in the risk of serious gastrointestinal bleeding is documented with Warfarin and other anticoagulants. An increased risk of GI ulceration or bleeding is also associated with co-administration of Oral Corticosteroids and SSRIs. Ketoprofen may diminish the therapeutic effect of ACE-inhibitors and diuretics. Alcohol (Ethanol) is noted as an independent risk factor for GI bleeding that is exacerbated when combined with Ketoprofen. Taking Aristal with food is documented to slow the rate of absorption, delaying the maximum plasma concentration. Elderly patients are formally classified as being at greater risk for serious gastrointestinal events during co-administration with interacting agents.

Mechanism of Action

How Aristal Works

Aristal (Ketoprofen) acts through nonselective inhibition of the cyclooxygenase (COX) enzymes, disrupting a primary signaling cascade responsible for various physiological processes.


Modulating the COX-Prostaglandin Pathway

This domain covers the drug's core molecular target: the COX-1 and COX-2 enzymes. By reversibly blocking these enzymes, Aristal prevents the conversion of arachidonic acid into potent lipid mediators called prostaglandins ( PGE2). This modification of the eicosanoid cascade alters activity within peripheral signaling pathways, influencing the drug’s systemic physiological consequences.


Regulating Peripheral and Central Signaling

This mechanism involves reducing signal transduction at multiple sites. Peripherally, the reduced synthesis of PGE2 alters the excitation state of nociceptors (pain receptors), modulating the physiological threshold required for the transmission of afferent signals. Centrally, the mechanism influences the hypothalamus, where PGE2 reduction resets the elevated thermoregulatory set point, initiating physiological mechanisms of heat dissipation.


Mechanistic Limitations

The nonselective nature of the enzyme inhibition affects the synthesis of inflammatory mediators but also modulates pathways crucial for homeostasis. The simultaneous blocking of the constitutive COX-1 enzyme impairs the synthesis of protective prostaglandins, representing a functional constraint of the mechanism that cannot be separated from its action profile.

Dosage and Administration Information

How Aristal is Used: Official Administration Guidelines

Aristal (Ketoprofen) is administered according to dosage principles and routes defined for either systemic or localized relief. The medicine is available for Oral administration via capsules and tablets, for Topical application as a gel, and in some markets, for Rectal use as a suppository.


Dosing and Frequency Patterns

The choice of formulation dictates the frequency of use. Immediate-release (IR) oral forms for acute pain or symptom flares are typically scheduled to be taken multiple times per day (such as three or four times daily), whereas extended-release (ER) forms are designed for once-daily administration. The overall prescribed dosage should not exceed the maximum daily limit, which is generally set at 300 mg for prescription systemic use. For non-prescription (OTC) oral use, the maximum daily limit is lower. The ER form is generally not recommended for acute pain and is reserved for chronic management.


Administration Context and Special Populations

For oral administration, the medicine may be taken with food, milk, or antacids to help minimize potential gastric effects, although this may slow the rate of absorption. Specific enteric-coated formulations may require administration apart from meals. Tablets and capsules, particularly the extended-release forms, must be swallowed whole without crushing or chewing. For specific populations, guidelines advise that older adults may require a lower initial dose due to age-related pharmacokinetic changes. Furthermore, the safety and effectiveness of prescription Ketoprofen are not established in children under 18 years of age. If a dose is missed, instructions specify to skip the missed dose and resume the next scheduled time, without doubling the amount taken.

Recent Clinical Evidence

Research evidence / Overview of Studies for Aristal (Ketoprofen)

This overview summarizes the structure and nature of the clinical research that has evaluated Aristal (ketoprofen), structured to adhere to official and peer-reviewed scientific sources. The text describes the study context, outcomes examined, and known limitations, without providing clinical advice, making therapeutic claims, or interpreting individual outcomes.


Evidence for Managing Chronic Inflammatory Conditions

The core research base for Aristal's systemic use was evaluated in research exploring chronic disorders like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis—conditions associated with joint pain, stiffness, and fluctuating physical discomfort.

This area was studied through numerous Randomized Controlled Trials (RCTs), which are summarized in Systematic Reviews and Meta-analyses, contributing to a high level of evidence in this landscape. Studies reported data related to measured values of outcomes related to physical discomfort and functional limitations reported by patients. However, a key limitation in many primary efficacy studies is that follow-up durations were limited, typically lasting only a few weeks to months, meaning that evidence related to the sustained effects over many years is not fully established.

Evidence for Short-Term Acute Pain and Inflammation

Aristal was also studied in research examining acute symptoms associated with episodic and disruptive conditions, such as postoperative pain following surgical procedures, severe acute symptoms of gouty arthritis, or primary dysmenorrhea (menstrual pain).

These research scenarios heavily relied on RCTs and subsequent Meta-analyses. The studies monitored outcomes describing episodic or acute changes, such as the time to onset of measured outcomes related to physical discomfort and the proportion of patients reaching a defined level of symptom change over a short time interval. As the focus of this research was on rapid symptom measurement, the ultra-short duration of follow-up is a significant research limitation.

Evidence for Localized Relief: Topical Formulations

The localized use of Aristal (topical formulations) was evaluated in research exploring conditions accessible on the skin surface, such as knee osteoarthritis. These studies reported data related to measured outcomes related to physical discomfort in comparison to topical placebo. However, the evidence is concentrated on the knee and remains limited for assessing symptoms in deeper or less accessible joints like the hip or spine.

Key Studies & References

  1. Systematic review and meta-analysis of ketoprofen for the treatment of pain
  2. NIH National Library of Medicine - MedlinePlus Drug Information: Ketoprofen

Frequently Asked Questions (FAQ)

Common questions about Aristal (FAQ)


Q: How is Aristal different from older or typical NSAID medicines?

A: Aristal is the brand name for the active ingredient Ketoprofen, which belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) class, similar to Ibuprofen and Naproxen. Regulatory documents indicate that Aristal has demonstrated effectiveness comparable to other NSAIDs in clinical studies for pain and inflammation. Comparative data in regulatory sources indicates that Ketoprofen may carry a different profile of gastrointestinal risk compared to other NSAIDs.


Q: Is Aristal used only for pain, or are there other conditions it treats?

A: Official approvals for Aristal (Ketoprofen) are for the relief of pain, including pain associated with menstrual cramps (primary dysmenorrhea). It is also officially approved for managing the signs and symptoms of certain chronic inflammatory conditions, such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.


Q: Are there any long-term side effects associated with taking Aristal?

A: Official warnings note that the risk of certain serious side effects may increase the longer the medicine is used. Specifically, the risk of serious cardiovascular events (such as heart attack and stroke) and serious gastrointestinal events (including bleeding and ulceration) may increase with the duration of use.


Q: What are the most common side effects people report when starting Aristal?

A: According to official adverse reaction data, commonly reported side effects (seen in 1% to 10% of patients) often include gastrointestinal issues like upset stomach, nausea, diarrhea, and gas. Nervous system effects such as headache, dizziness, and drowsiness are also reported in this frequency range.


Q: How long does it usually take to feel the effects of Aristal?

A: Pharmacokinetic data from regulatory documents provide insight into how quickly the medicine enters the bloodstream. For immediate-release oral forms of Aristal, the time to reach maximum concentration in the blood is generally within 30 minutes to 2 hours after administration.


Q: Can Aristal affect a person's driving ability or ability to operate machinery?

A: Side effects such as dizziness, drowsiness, or blurred vision may occur while taking Aristal. Official warnings note that activities requiring alertness, such as driving or operating heavy machinery, may be affected.


Q: Does Aristal interact with alcohol?

A: Official patient information notes that taking Aristal while consuming three or more alcoholic drinks daily can increase the risk of stomach bleeding. Alcohol is considered an independent risk factor that is exacerbated by the use of this medication.


Q: Is it safe to use Aristal during pregnancy or while breastfeeding?

A: Use of Aristal is strictly prohibited from 30 weeks of pregnancy onward due to the risk of harm to the fetus. Prior to 30 weeks, the regulatory classification advises that a risk-benefit assessment must be considered. For breastfeeding, official information states that because sufficient studies are not available, a decision on use requires a careful weighing of potential benefits against risks.


Q: Is Aristal safe for children and adolescents?

A: Official regulatory documents state that the safety and effectiveness of Aristal (Ketoprofen) have not been established in the pediatric population, which includes children under 18 years of age.


Q: What is the general expectation for how long people need to take Aristal?

A: Aristal is prescribed for both acute pain (short-term use) and for the chronic management of conditions like arthritis using extended-release forms. However, official warnings advise that the risk of serious side effects increases the longer the medicine is taken.


Q: Does Aristal interact with antidepressant medications?

A: Regulatory documents explicitly warn that combining Aristal with Selective Serotonin Reuptake Inhibitors (SSRIs), a type of antidepressant, increases the risk of gastrointestinal bleeding.


Q: Is it safe to take Aristal with common over-the-counter medications?

A: Official warnings state that Aristal should not be used in combination with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which are present in many over-the-counter pain relievers. Combining Aristal with other NSAIDs increases the likelihood of side effects, according to regulatory warnings.


Q: Does Aristal have a known effect on sexual function or libido?

A: Official documentation lists 'libido disturbance' as a possible adverse reaction. However, this effect is not reported as common in regulatory safety profiles.


Q: Are the research findings on Aristal mostly for short-term use or also for long-term use?

A: Clinical trials support the use of Aristal for both acute and chronic conditions. However, a limitation noted in research overviews is that the follow-up periods in many efficacy studies were typically limited to only a few weeks or months, meaning long-term data over many years may be less established.


Q: Is Aristal a generic medicine or is it only available as a brand name?

A: Aristal is a brand name for the active ingredient Ketoprofen. The active ingredient itself is also available as a generic medicine.


Q: Does Aristal affect cholesterol levels or other metabolic factors?

A: Official adverse reaction data includes metabolic changes. Regulatory documents list 'dyslipidemia' (abnormal lipid levels, which includes cholesterol) and aggravated diabetes mellitus as adverse reactions.


Q: Why is Aristal sometimes referred to as a 'third-generation' antipsychotic?

A: Aristal is officially classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is used to treat pain and inflammation. The term 'third-generation antipsychotic' refers to a completely different class of medication used to treat psychiatric disorders, indicating a common user misunderstanding of the drug name.


Q: Can I take Aristal with my vitamin and herbal supplements?

A: Official regulatory texts advise patients to inform their healthcare providers about all products they use, including nonprescription drugs, vitamins, and herbal products, before starting Aristal.


Q: What are the official uses of Aristal based on regulatory approvals?

A: Official regulatory approvals list the uses of Aristal as the treatment of mild to moderate pain (including menstrual cramps) and the management of signs and symptoms related to chronic conditions like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.


Q: Is it normal to feel a bit restless or agitated when first starting Aristal?

A: Official documentation lists 'nervousness' and 'insomnia' as common side effects (seen in 1% to 10% of patients). 'Anxiety' is listed as a less frequent adverse reaction.


Q: Can taking Aristal affect my body temperature regulation?

A: Yes, Aristal's mechanism of action involves influencing the brain's hypothalamus to reset an elevated thermoregulatory set point. This physiological effect is the basis for its action as an antipyretic, meaning it helps reduce fever.


Q: Has Aristal been studied for use in conditions like OCD or PTSD?

A: The clinical trials documented in regulatory information focus on the efficacy of Aristal for inflammatory and pain-related conditions, such as arthritis and acute pain. No studies evaluating its use for conditions like Obsessive-Compulsive Disorder (OCD) or Post-Traumatic Stress Disorder (PTSD) are described in the official indications.

How should Aristal be stored and disposed of?

How to Store and Dispose of Aristal (Ketoprofen)

Aristal (Ketoprofen) must be stored strictly according to official regulatory labeling to maintain product stability and safety. The medication must be kept at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Storage areas must protect the product from freezing, excessive heat, moisture, and direct light.

Packaging and Child Safety

The medicine should be kept in its original container and the cap must be tightly closed using a child-resistant closure. It is required that all medication is stored out of the sight and reach of children.

Official Disposal Rules

Unused or expired Aristal should ideally be disposed of using a local drug take-back program. If a take-back program is unavailable, the medicine should be removed from its container, mixed with an undesirable substance (such as used coffee grounds), sealed in a bag, and then placed in the household trash. The product must not be flushed down the toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aristal found in:

A-Z Index: